NASDAQ:CADL

Candel Therapeutics Stock Predictions

etoro logo Buy CADL
*Your capital is at risk
$8.80
+0.380 (+4.51%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CADL Prediction Chart

CADL Predictions History

Latest community submissions for CADL.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 23, 2025 $4.52 -4.60% $4.76 X 95.00% 0
Apr 23, 2025 $4.87 +2.70% $4.76 V 97.73% 1
Apr 23, 2025 Bullish $4.76 V 1
Apr 15, 2025 $4.92 -4.82% $4.95 V 99.41% 4
Apr 15, 2025 $5.01 -3.01% $4.95 V 98.70% 2
Apr 15, 2025 Bullish $4.95 X 0
Apr 1, 2025 Bullish $5.57 X 0
Mar 31, 2025 $6.25 +5.10% $5.65 X 89.32% 0
Mar 31, 2025 $6.14 +3.16% $5.65 X 91.37% 0
Mar 31, 2025 Bullish $5.65 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CADL with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CANDEL THERAPEUTICS, INC.
Candel Therapeutics
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of hi...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE